文献速递免疫规划

利用第二生命年(2YL)平台开展补种疫苗接种以缩小免疫 gap:巴基斯坦、菲律宾和南非的 DHS 二次分析

Use of catch-up vaccinations in the second year of life (2YL) platform to close immunity gaps: A secondary DHS analysis in Pakistan, Philippines, and South Africa.
PubMed 文献 · Vaccine · 2022-11-14

该研究基于巴基斯坦(2017-2018)、菲律宾(2017)和南非(2016)的人口与健康调查(DHS)数据,对24-35月龄儿童进行时间-事件分析,评估第二生命年(2YL)平台用于补种疫苗接种的情况。结果显示三国2YL期间百白破-乙肝-Hib五联疫苗第三剂覆盖率分别提升2%、3%、1%,含麻疹成分疫苗第一剂(MCV1)覆盖率分别提升5%、10%、3%,但仍有大量补种机会被遗漏。作者认为2YL平台可提高覆盖率并缩小免疫 gap,但免疫规划需改变政策、实践并监测补种疫苗接种以最大化其潜力。

要点

  • 三国2YL平台使五联疫苗第三剂覆盖率提升1%-3%,MCV1覆盖率提升3%-10%。
  • 在MCV接种访视时,巴基斯坦45%、菲律宾38%的合格儿童获得五联疫苗补种,南非仅20%。
  • 许多补种机会仍被遗漏,需改变政策与实践并监测补种疫苗接种。

核心结论

  • 三国通过2YL补种疫苗接种均获得小幅至中等程度的疫苗覆盖率提升,但许多补种机会仍被遗漏。
  • 使用2YL平台可提高覆盖率并缩小免疫 gap,但免疫规划需改变政策、实践并监测补种疫苗接种以最大化其潜力。

研究设计与样本

  • 对巴基斯坦(2017-2018)、菲律宾(2017)和南非(2016)的人口与健康调查(DHS)免疫数据进行二次数据分析。
  • 对百白破-乙肝-Hib五联疫苗和含麻疹成分疫苗(MCV)进行时间-事件分析,计算2YL和MCV访视用于补种疫苗接种的比例。
  • 分析对象为有记录日期的24-35月龄儿童。

主要发现

  • 在有记录日期的24-35月龄儿童中,五联疫苗第三剂覆盖率在2YL期间分别提升:巴基斯坦2%、菲律宾3%、南非1%。
  • MCV1覆盖率在2YL期间分别提升:巴基斯坦5%、菲律宾10%、南非3%。
  • 巴基斯坦:在有记录MCV访视时符合五联疫苗补种条件的124名儿童中,45%获得了补种剂量。
  • 菲律宾:在381名符合条件儿童中,38%在MCV访视期间获得了五联疫苗剂量。
  • 南非:50名儿童在MCV1访视前符合五联疫苗补种条件,但仅20%获得补种;无人在MCV2访视时获得补种。

临床怎么用

  • 原文结论指出使用2YL平台可提高覆盖率并缩小免疫 gap,但免疫规划需改变政策、实践并监测补种疫苗接种以最大化其潜力。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immunity gaps caused by COVID-19-related disruptions highlight the importance of catch-up vaccination. Number of countries offering vaccines in second year of life (2YL) has increased, but use of 2YL for catch-up vaccination has been variable. We assessed pre-pandemic use of 2YL for catch-up vaccination in three countries (Pakistan, the Philippines, and South Africa), based on existence of a 2YL platform (demonstrated by offering second dose of measles-containing vaccine (MCV2) in 2YL), proportion of card availability, and geographical variety. METHODS: We conducted a secondary data analysis of immunization data from Demographic and Health Surveys (DHS) in Pakistan (2017-2018), the Philippines (2017), and South Africa (2016). We conducted time-to-event analyses for pentavalent vaccine (diphtheria-tetanus-pertussis-Hepatitis B-Haemophilus influenzae type b [Hib]) and MCV and calculated use of 2YL and MCV visits for catch-up vaccination. RESULTS: Among 24-35-month-olds with documented dates, coverage of third dose of pentavalent vaccine increased in 2YL by 2%, 3%, and 1% in Pakistan, Philippines, and South Africa, respectively. MCV1 coverage increased in 2YL by 5% in Pakistan, 10% in the Philippines, and 3% in South Africa. In Pakistan, among 124 children eligible for catch-up vaccination of pentavalent vaccine at time of a documented MCV visit, 45% received a catch-up dose. In the Philippines, among 381 eligible children, 38% received a pentavalent dose during an MCV visit. In South Africa, 50 children were eligible for a pentavalent vaccine dose before their MCV1 visit, but only 20% received it; none with MCV2. CONCLUSION: Small to modest vaccine coverage improvements occurred in all three countries through catch-up vaccination in 2YL but many missed opportunities for vaccination continue to occur. Using the 2YL platform can increase coverage and close immunity gaps, but immunization programmes need to change policies, practices, and monitor catch-up vaccination to maximize the potential.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Manandhar P, Wannemuehler K, Danovaro-Holliday MC, et al. Use of catch-up vaccinations in the second year of life (2YL) platform to close immunity gaps: A secondary DHS analysis in Pakistan, Philippines, and South Africa. Vaccine. 2022. PMID: 36396512. doi:10.1016/j.vaccine.2022.10.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。